Arthritis Archives - Archived News & Historical Arthritis Articles

The latest news related blogs on arthritis.

Keep up with the latest in arthritis. Subscribe to our free weekly newsletter.

03/19/2005, Reputable charities do important work; but beware of sound-alike charity scams.

05/29/2004, Celebrex appears to have lower risk of congestive heart failure, according to Canadian study.

07/10/2003, Canada adopts "interim measure" to sell marijuana and seeds to medically eligible people.

05/13/2003, Genentech and Xoma stop development of the drug Raptiva (efalizumab) for rheumatoid arthritis.

05/07/2003, NIAMS is funding a study to assess the effectiveness of gabapentin for the treatment of fibromyalgia.

04/22/2003, Arthritis Foundation encourages people with arthritis to seek more life and less limitations.

03/09/2003, A look at the newest arthritis medications in 2003.

03/07/2003, The risk versus benefit of Arava, Enbrel, Remicade, and Humira was reconsidered.

12/31/2002, Humira is the first human monoclonal antibody approved for rheumatoid arthritis.

12/24/2002, Enbrel is in the news. Amgen Working To meet Enbrel demand. Application submitted for once-weekly dosing.

12/03/2002, Improved Enbrel availability great news for arthritis patients.

10/29/2002, Amgen submits request for new Enbrel indications; Long-term study results are positive.

10/15/2002, Humira (adalimumab) was made available to rheumatoid arthritis patients in need of other treatment options.

08/26/2002, Researchers suggest that glycosaminoglycans, or GAGs, may cause RA.

06/24/2002, Abbott filed for regulatory approval of Humira (adalimumab).

06/10/2002: Stanford Chronic Disease Self-Management Program found to delay disability.

03/13/2002, "LillyAnswers" concluded May 15, 2006, but a new assistance program "LillyMedicareAnswers" is expected to become available by early 2007.

01/16/2002, Enbrel was FDA approved for the treatment of psoriatic arthritis.

01/12/2002: FDA approves Ascension MCP, a two-component implant for the metacarpophalangeal (MCP) joint.

11/18/2001, FDA approves Kineret (anakinra) for rheumatoid arthritis patients who have failed DMARDs.

10/24/2001, Remicade (infliximab) maker halts trial designed to assess use for congestive heart failure (CHF).

10/07/2001, Co-workers help wheelchair-users to safety with evacuation chairs during WTC tragedy.

09/20/2001, FDA announces second major recall of hip implants within the past year.

8/19/2001, FDA Arthritis Advisory Committee voted to recommend Kineret (anakinra) for approval.

06/30/2001, Adalimumab (Humira) to be the first fully human anti-TNF therapy for rheumatoid arthritis.

06/25/2001, Osteoarthritis Initiative (OIA) is launched by NIH.

06/18/2001, Amgen presents study data for Anakinra (Kineret) and Pegsunercept (PEG sTNF-R1).

05/24/2001, Sulzer updates recall of the Inter-Op hip implant. FDA told there may also be problems with a knee implant.

04/22/2001, FDA Arthritis Advisory Committee not overwhelmingly in favor of new lupus drug that was later named Prestara.

03/15/2001, EMEA issues public statement regarding Arava and serious hepatic reactions.

02/28/2001, Railroad workers with carpal tunnel syndrome secretly tested.

02/18/2001, Are doctors decisions about which drugs to prescribe influenced by sales reps?

02/09/2001, Drug manufacturers ask FDA to remove ulcer warnings.

01/20/2001, Certain hip implants made by Sulzer Orthopedics were recalled.

12/10/2000, Enbrel was approved in Canada. Since demand has soared, U.S. began enrollment program.

10/14/2000, Immunex sent over 100,000 letters to doctors and pharmacists issuing new warnings.

08/26/2000, Aida Turturro becomes spokesperson for rheumatoid arthritis.

08/17/2000, A consumer protection group brings suit over unsupported health claims for magnetic shoes.

05/23/2000, Study offers assessment of direct and indirect costs of seropositive rheumatoid arthritis.

04/14/2000, FDA approved Mobic (Meloxicam) for the treatment of osteoarthritis.

04/12/2000, Consumer Lab tests 13 brands of SAM-e and the results are surprising.

02/20/2000, Study shows Celebrex does not interfere with normal platelet function.

12/28/1999, An overview of the similarities and differences between the COX-2 inhibitors Celebrex and Vioxx.

12/18/1999, The drugmaker SmithKline is sued over LYMErix the Lyme disease vaccine.

11/15/1999, Remicade (infliximab) was FDA approved for treatment of rheumatoid arthritis.

10/05/1999, NIH awards major AS research grant to continue work started by patient advocates.

08/29/1999, Enbrel study results indicate improvement in the signs and symptoms of psoriatic arthritis.

08/09/1999, A new label application for Enbrel seeks indications for slowing structural damage and improving symptoms of early, active RA.

06/27/1999, FTC making effort to combat fraudulent health websites on the Internet.

06/15/1999, Results from ATTRACT clinical trial revealed favorable results for Remicade (infliximab).

06/03/1999, COX-2 enzyme (cyclooxygenase 2) may have anti-inflammatory properties which occur later in the inflammation process.

05/27/1999, Vioxx was approved by the FDA.

05/20/1999, Enbrel had warnings added to its label just 5 months after it was FDA approved and marketed.

05/09/1999, Follow-up analysis indicates concern over Celebrex report was overblown.

04/21/1999, Reports in the news about Celebrex cause concern, the FDA stresses no need for alarm.

03/10/1999, People at risk for Lyme disease were urged to become vaccinated. In February 2002, the maker of LYMErix (the Lyme vaccine) announced they would stop producing the vaccine.

02/17/1999, Bone marrow transplant shows promise in battling severe juvenile chronic arthritis.

02/02/1999, Study shows significant benefit combining Enbrel with methotrexate for treatment of rheumatoid arthritis.

01/27/1999, FDA issues a deficiency letter in regard to the pending approval of Prosorba.

01/03/1999, FDA approves Celebrex (celecoxib) for osteoarthritis and rheumatoid arthritis.

12/02/1998, FDA advisory panel unanimously recommends the approval of Celebrex for osteoarthritis and rheumatoid arthritis.

11/05/1998, FDA approved Enbrel (etanercept) for the treatment of rheumatoid arthritis.

09/24/1998, Enbrel was unanimously recommended for FDA approval for the treatment of active rheumatoid arthritis.

09/16/1998, Arava is FDA approved for the treatment of active rheumatoid arthritis in adults.

08/12/1998, Arava was unanimously recommended for FDA approval.

06/23/1998, Researcher Phillip Needleman key in COX-2 selective inhibitor development.

05/22/1998, Americans with Disabilities Act (ADA) has gone awry. Purpose is not congruent with reality.

04/21/1998, Researchers find protein in lizard's blood which kills Lyme disease bacteria in ticks.

03/10/1998, Dr. Jack Kevorkian helped a rheumatoid arthritis sufferer and a fibromyalgia sufferer end their lives.

02/10/1998: Professional golfer Casey Martin sues the PGA Tour under the Americans with Disabilities Act.

01/20/1998, The Arthritis Foundation begins nationwide 50th anniversary observance.

08/12/1997, Medicinal marijuana is debated in both political and medical arenas.

06/22/1997, Researchers optimistic about clinical trial results of Enbrel.

03/13/1997, After 15 years without new treatment options, newer biologic drugs for RA were on the way.

03/07/1997, Advances in joint replacement surgery provide higher quality of life.